Scisparc Stock In The News

SPRC Stock  USD 0.38  0.03  8.57%   
Our overall analysis of Scisparc's news coverage and content from conventional and social sources shows investors' bearish mood towards Scisparc. The specific impact of Scisparc news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Scisparc's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Scisparc headlines in addition to utilizing other, more conventional financial analysis modules. Check out Scisparc Backtesting and Scisparc Hype Analysis.
For information on how to trade Scisparc Stock refer to our How to Trade Scisparc Stock guide.

Scisparc Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
SciSparc-Clearmind Collaboration Leads t...
https://www.globenewswire.com/news-release/2025/03/10/3039647/0/en/SciSparc-Clearmind-Collaboration-Leads-to-Publication-of-Patent-Application-for-Cocaine-Addiction-Psychedelic-Combination-Treatment-in-South-Korea.html
 Neutral
Macroaxis News: globenewswire.com
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
https://www.globenewswire.com/news-release/2025/03/10/3039620/0/en/Clearmind-Medicine-Announces-Publication-of-Patent-for-Cocaine-Addiction-Psychedelic-Combination-Treatment-in-South-Korea.html
 Bullish
Macroaxis News: globenewswire.com
SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers
https://www.globenewswire.com/news-release/2025/03/03/3035613/0/en/SciSparc-Signs-Definitive-Agreement-to-Sell-MitoCareX-Computational-Drug-Discovery-Company-Targeting-Resistant-Cancers.html
 Bullish
Macroaxis News: globenewswire.com
SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles
https://www.globenewswire.com/news-release/2025/02/27/3033874/0/en/SciSparc-Extends-2-Million-Loan-to-Support-AutoMax-s-Growth-Following-AutoMax-s-Entry-into-Direct-Import-of-JAC-Electric-Vehicles.html
 Bullish
Macroaxis News: globenewswire.com
N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers
https://www.globenewswire.com/news-release/2025/02/26/3033018/0/en/N2OFF-Signs-Definitive-Agreement-to-Acquire-Next-Gen-Computational-Drug-Discovery-Company-Targeting-Hard-To-Treat-Cancers.html
 Bullish
Macroaxis News: globenewswire.com
SciSparc Secures Favorable Settlement in...
https://www.globenewswire.com/news-release/2025/02/18/3027706/0/en/SciSparc-Secures-Favorable-Settlement-in-Lawsuit-It-Filed-Receiving-Cash-Compensation-and-a-Full-Release-from-All-Commitments-Royalties-and-Allegations-Asserted-Against-It-on-Claim.html
 Bullish
Macroaxis News: globenewswire.com
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
https://www.globenewswire.com/news-release/2025/02/04/3020343/0/en/Clearmind-Medicine-Announces-Publication-of-Patent-for-Binge-Behavior-Psychedelic-Combination-Treatment-in-Mexico.html
 Neutral
Macroaxis News: globenewswire.com
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
https://www.globenewswire.com/news-release/2025/01/15/3009942/0/en/SciSparc-Granted-180-Day-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Requirement.html
 Neutral
Macroaxis News: globenewswire.com
SciSparc Adopts Limited Duration Shareholder Rights Plan
https://www.globenewswire.com/news-release/2023/11/28/2786996/0/en/SciSparc-Adopts-Limited-Duration-Shareholder-Rights-Plan.html
 Bullish
Macroaxis News: globenewswire.com
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
https://www.globenewswire.com/news-release/2023/11/28/2786939/0/en/SciSparc-Announces-Positive-Results-from-its-Weight-Loss-and-Metabolic-Disorder-Program-with-its-Proprietary-Psychedelic-Based-Treatment.html
 Bullish

Scisparc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Scisparc and other traded companies coverage with news coverage. We help investors stay connected with Scisparc headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Scisparc Stock performance. Please note that trading solely based on the Scisparc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Scisparc's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Scisparc investors visualize upcoming and past events in order to time the market based on Scisparc noise-free hype analysis.
Scisparc stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Scisparc earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Scisparc that are available to investors today. That information is available publicly through Scisparc media outlets and privately through word of mouth or via Scisparc internal channels. However, regardless of the origin, that massive amount of Scisparc data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Scisparc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Scisparc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Scisparc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Scisparc alpha.

Scisparc Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Scisparc Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
10th of March 2025
SciSparc-Clearmind Collaboration Leads to Publication of Patent Application for Cocaine Ad...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
3rd of March 2025
SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Compan...
at gurufocus.com 
Yahoo News
27th of February 2025
SciSparc Extends 2 Million Loan to Support AutoMaxs Growth Following AutoMaxs Entry into D...
at finance.yahoo.com 
Yahoo News
18th of February 2025
SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
15th of January 2025
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Require...
at gurufocus.com 
Gurufocus Stories at Macroaxis
13th of January 2025
SciSparc AutoMax Enters the Direct Import Market with a 13 Million First Shipment of JAC ....
at gurufocus.com 
Yahoo News
7th of January 2025
SciSparc MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Po...
at finance.yahoo.com 
Yahoo News
6th of January 2025
Clearmind Medicine Announces the Publication of European Patent Application for Binge Beha...
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
31st of December 2024
SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical...
at gurufocus.com 
Yahoo News
26th of December 2024
SciSparc AutoMax Announces 13 Million First Delivery of JAC Vehicles Following Regulatory ...
at finance.yahoo.com 

Scisparc Investors Sentiment

The influence of Scisparc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Scisparc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Scisparc's public news can be used to forecast risks associated with an investment in Scisparc. The trend in average sentiment can be used to explain how an investor holding Scisparc can time the market purely based on public headlines and social activities around Scisparc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Scisparc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Scisparc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Scisparc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Scisparc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Scisparc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Scisparc's short interest history, or implied volatility extrapolated from Scisparc options trading.
When determining whether Scisparc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scisparc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scisparc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scisparc Stock:
Check out Scisparc Backtesting and Scisparc Hype Analysis.
For information on how to trade Scisparc Stock refer to our How to Trade Scisparc Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scisparc. If investors know Scisparc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scisparc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.28)
Revenue Per Share
1.357
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.39)
Return On Equity
(0.86)
The market value of Scisparc is measured differently than its book value, which is the value of Scisparc that is recorded on the company's balance sheet. Investors also form their own opinion of Scisparc's value that differs from its market value or its book value, called intrinsic value, which is Scisparc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scisparc's market value can be influenced by many factors that don't directly affect Scisparc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scisparc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scisparc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scisparc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.